Check out what we’ve been up to and where we can connect!
June 12, 2020
Claudia Christian, Senior VP, Clinical Operations, recently spoke with Seth Gulledge, writer for the Research Triangle Park, North Carolina-based Triangle Business Journal, about how the COVID-19 pandemic has disrupted the traditional model for clinical trials. This has prompted CROs around the Triangle to rapidly integrate virtual trial models to speed up clinical research and push COVID-19 vaccines and therapies to market.
June 8, 2020
Today, we commit to being better and doing more. We will continue consulting and partnering with the communities where we work, and we will redouble our efforts to ensure that their voices inform and shape the way we do our work. We will reexamine our internal structures and evolve our practices to root out imbalances and inequality and ensure that everyone is represented, included and empowered.
May 22, 2020
Preliminary results of the Adaptive COVID-19 Treatment Trial (ACTT) investigating remdesivir for the treatment of COVID-19 in hospitalized adults with evidence of lower respiratory tract involvement has been published in the New England Journal of Medicine . Of the FHI Clinical study team members, Danielle Fisher, Clinical Research Project Manager, and Wendi McDonald, Associate Project Manager, are listed on the manuscript for her contributions to the study.
April 16, 2020
Our president and CEO, Ted FitzGerald, talks with Outsourcing-Pharma about our partnership with IDRI on an immunotherapy clinical trial to combat COVID-19.
August 11, 2020
Patient safety and data integrity remain of utmost importance as CROs navigate shifting regulatory guidelines, reevaluate their existing strategies and reprioritize IT projects. Register to learn how the pandemic has transformed the clinical trial landscape, the operational shifts that are needed within CROs, the technologies that have been most impactful and some of the obstacles and barriers to transformation.
Missed the webinar? View the recording for an inside perspective regarding proper planning and implementation of process workflows and unified technology platforms to allow study teams to manage better quality data, more efficiently, and gain critical insights in support of clinical development programs.
Missed the webinar? View the recording to hear industry infectious disease experts discuss the importance of quality historical, testing and tracking data for timely, coordinated responses to outbreaks.
An FHI Clinical representative will be present at the Medical Technology Enterprise Consortium’s (MTEC) 5th Annual Membership Meeting in Houston, TX, March 4-5, 2020. Set up a meeting to discuss FHI Clinical’s global operational experience.
FHI Clinical representatives will be present at the 11th Annual SCOPE Summit in Orlando, FL, February 18-21, 2020. Set up a meeting to discuss FHI Clinical’s operational experience around the world.
FHI Clinical Headquarters
359 Blackwell Street, Suite 200
Durham, NC 27701 USA